Benjamin Solomon

Sep 28, 2016

Opko Health has appointed Benjamin Solomon as managing director of GeneDx, part of Opko's BioReference Laboratories subsidiary. Solomon comes to Opko from Inova Translational Medicine Institute, where he most recently served as chief of the division of medical genomics. He attended medical school at Geisel School of Medicine at Dartmouth College and completed his residency and fellowship training in pediatric medicine and clinical genetics at the National Human Genome Research Institute and at Children's National Medical Center. Solomon is a board-certified pediatrician in clinical genetics and pediatrics.

More Like This

Jul 21, 2017

Thomas Loewald

Thomas Loewald, senior vice president and chief commercial officer at Thermo Fisher Scientific since early 2016, will resign from the company, effective September 1. He joined the firm's Explosives Detection business in 2002 and held various positions over the years, including senior vice president and president of Laboratory Products. Prior to that, he was vice president of sales and marketing for Tyco International.

Jul 20, 2017

Mark Stevenson

Mark Stevenson has been promoted to executive vice president and chief operation officer of Thermo Fisher Scientific, effective August 1. In his new role, he will oversee operations of the company's Laboratory Products and Analytical Instruments businesses, in addition to the Life Sciences Solutions business. Since 2014, when Thermo Fisher acquired Life Technologies, Stevenson has been executive vice president and president of Life Sciences Solutions. Prior to that, he was president and chief operating officer of Life Technologies, and before that, he was president and COO of Applied Biosystems.

Jul 19, 2017

Lew Titterton

Lew Titterton has rejoined the board of Itus. He was previously on the firm's board from 2010 to 2016, and was its chairman during the last four years of his previous tenure. He was also a director at Itus between 1999 and 2003. Titterton is currently chairman of the board at NYMED.

Jul 18, 2017

Anna Chérouvrier Hansson, Henrik Appelgren

Anna Chérouvrier Hansson is joining SenzaGen as the firm's chief commercial officer, and Henrik Appelgren will become its chief scientific officer. The firm said that the appointments are the final steps as it prepares to commercialize its GARD tests and to list on the Nasdaq First North. Hansson most recently was the director of marketing at Camurus. She begins her new job on Aug. 15. Appelgren has been with the Swedish Chemicals Agency for 15 years, where he was Sweden's national coordinator in the OECD Test Guideline Programme. He joins SenzaGen on Sept. 4. 


Jul 17, 2017

Stephen Pereira

Stephen Pereira has been appointed to Immunovia's scientific advisory board. Pereira is a professor of hepatology and gastroenterology at University College London and is an honorary consultant in pancreaticobiliary medicine at UCL Hospitals and the Royal Free Hospital. 

Jul 07, 2017

Matthias Raquet

Oneservice, a Swiss company offering complete managed service solutions, consulting, and learning for the life science, diagnostics, and medical device industries, has appointed Matthias Raquet as CEO. Raquet joins Oneservice from Qiagen, where he has worked since 2001, most recently as vice president and head of global service solutions and global customer management. Prior to Qiagen he worked in various management roles at Amersham Pharmacia.

Jul 07, 2017

Amit Kumar, Robert Berman, Mike Catelani

Amit Kumar was named president and CEO of Itus, which is developing blood-based solid tumor cancer diagnostics. He replaces Robert Berman, who resigned as president, CEO, and as a director. Kumar, formerly CEO of CombiMatrix, has been the executive chairman of Itus for the past year, and has been a director since joining the firm in 2012. Also, Mike Catelani, Itus' CFO, has been promoted to chief operating officer. 

Jul 06, 2017

Richard Davis

Qualigen announced Richard Davis has been elected to its board, effective June 26. David is an associate clinical professor of urology at the David Geffen School of Medicine at the University of California, Los Angeles, as well as chief of surgery at Motion Picture and Television Hospital. He is on the staff of several hospitals, as well. 

Jul 06, 2017

Gail Page

Gail Page has joined the board of Chembio Diagnostics. Page is the founder of Vineyard Investment Advisors, and previously was president and CEO of Vermillion. She also served as executive vice president and COO of Luminex. 

Jul 05, 2017

Patrick Kennedy

Former Congressman Patrick Kennedy has joined the board of Medibio, an Australian firm developing biomarker-based tests for the diagnosis and management of mental disorders, including depression and chronic stress. Kennedy was an eight-term member of Congress, where he represented Rhode Island. 


Jul 05, 2017

Chad Brown

NanoString Technologies has appointed Chad Brown senior vice president of sales and marketing. With more than 35 years of experience in life science tools and clinical diagnostics, Brown most recently served as the president and head of commercial operations for North America at Qiagen. Prior to that, Brown was with Roche Diagnostics Corporation, where he held a series of commercial leadership positions in the applied sciences and centralized diagnostics businesses. He has also held sales leadership positions in several medical device and healthcare companies, including Chiron Diagnostics, Rotech Healthcare, Apria Healthcare, and Humana.

Brown succeeds Barney Saunders, who is expected to stay with NanoString for a three-month transition period before pursuing other professional opportunities.

Jun 30, 2017

Todd Whitson

Karius has appointed Todd Whitson as chief commercial officer. Whitson joins Karius from CareDx where he served as CCO. Prior to CareDx, he served as VP of commercial operations for Ariosa Diagnostics, now part of Roche, and led sales at Genzyme Genetics, later acquired by LabCorp.

Jun 29, 2017

Eric Whitters, Tommy Chiu, Ulf Bladin, Kim Walker

HYCOR Biomedical has appointed Eric Whitters as chief operating officer, Tommy Chiu as VP of operations, Ulf Bladin as VP and general manager for EMEA territory, and Kim Walkers as VP of regulatory, quality, and clinical affairs. Whitters comes to HYCOR with more than 22 years of experience working for various sources including Fortune 500 organizations and niche diagnostic companies. Chiu comes to HYCOR with over 34 years of experience in the in vitro diagnostic industry working for companies, such as Diagnostic Products (now called Siemens Healthcare Diagnostics) and Astute Medical. Bladin brings 25 years of diagnostic and pharmaceutical experience in sales, marketing, strategic positioning and successful product launches at Merck Sharp & Dohme, and Pfizer. Walker joins HYCOR after running her own consulting business for 11 years, and previously serving as manager of regulatory affairs at Beckman Coulter.

Jun 28, 2017

Xavier Reveles

Bioaffinity Technologies announced the addition of Xavier Reveles as director of operations. He will manage the commercialization of Bioaffinity's diagnostic and therapeutic products. Reveles has 25 years of experience as a clinical geneticist and was laboratory director for Oncopath Laboratory-START Cancer Center. 

Jun 27, 2017

Lisa Kerber, Stephen Silvestro, Fernando Schwartz

Prognos named new members to its management team, including Lisa Kerber as chief operating officer, Stephen Silvestro as chief commercial officer, and Fernando Schwartz as chief data scientist. Kerber had several roles at QuintilesIMS, and was most recently the US VP and GM, Real World Evidence. Silvestro was most recently executive VP, head of global sales at Decision Resources Group. Schwartz was previously at LiveIntent, where he was chief data scientist.